AF

Angela L. Ferguson

The University of Sydney, Centenary Institute

Research areas: Medicine · Oncology · Cancer Immunotherapy and Biomarkers · Cutaneous Melanoma Detection and Management · Immune cells in cancer

ORCID iD 0000-0001-5974-0423

Employment

Education

Education history is unavailable.

Projects & Funding

  • Immunosuppression and the tumour microenvironment in advanced melanoma Australian Melanoma research foundation
    2023 - 2024
  • ProCel Study- Perioperative PROpranolol and CELecoxib in stage III melanoma: modifying the melanoma microenvironment to reduce metastatic risk Sydney Cancer Partners
    2023 - 2024
  • A single-dose, globally accessible vaccine to combat emerging SARS-CoV-2 variants Medical Research Future Fund
    2021 - 2023
  • Exploring functional capabilities of immune cells in the Tumour microenvironment (TME) to determine patient responses to immunotherapy Sydney Catalyst
    2019 - 2020
  • CD4+ T cell programming by early life and neonatal infection National Health and Medical Research Council
    2008 - 2008
  • CD4+ T-cell programming in early life and neonatal infection GlaxoSmithKline Australia
    2006 - 2008
  • CD4+ T-cell programming in early life and neonatal infection National Health and Medical Research Council
  • Identifying the immune populations driving response to immune checkpoint blockade therapies Sydney Cancer Partners

Publications

Publications are unavailable.